India Sends Chinese-Made Japanese Encephalitis Vaccine To Flooded Province Despite Doubts
This article was originally published in PharmAsia News
Executive Summary
India's Health Ministry says it has sent Chinese-made vaccines against Japanese encephalitis to flood-hit areas of the state of Bihar to guard against an epidemic. India imported 12 million doses of the vaccine from China two years ago, relying on that country's monopoly in the market and its several drugs in development. Some doubts about the safety of the drug have been raised despite China's success in protecting 200 million Chinese children with the vaccine. The chief concern is the vaccine is based on a live attenuated virus that could multiply and recombine with local viruses, creating a new strain. An Indian-made vaccine is 1-2 years from the market, according to the health secretary. (Click here for more
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.